title: [Nicorandil and ulceration: a physiopathological hypothesis].
authors.affiliation: Service de dermatologie, hôpital Brabois, bâtiment P.-Canton, rue du Morvan, 54511 Vandœuvre-lès-Nancy cedex, France. jl.schmutz@chu-nancy.fr
authors.forename: J L
authors.initials: JL
authors.lastname: Schmutz
authors.forename: P
authors.initials: P
authors.lastname: Trechot
mesh_terms: D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy*; D003875:Drug Eruptions / Q000097:blood / Q000209:etiology*; D006801:Humans; D009243:NAD / Q000097:blood; D009249:NADP / Q000097:blood; D009525:Niacin / Q000009:adverse effects / Q000493:pharmacokinetics; D009536:Niacinamide / Q000009:adverse effects / Q000493:pharmacokinetics; D020108:Nicorandil / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects / Q000378:metabolism; D012883:Skin Ulcer / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D014665:Vasodilator Agents; D009243:NAD; D009536:Niacinamide; D020108:Nicorandil; D009525:Niacin; D009249:NADP